Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)

NCT07525466 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Extranodal NK T Cell Lymphoma
Hemophagocytic Lymphohistiocytosis (HLH)

Interventions

DRUG: Mitoxantrone liposome
DRUG: Etoposide
DRUG: Pegaspargase (PEG) Asparaginase
DRUG: methylprednisolone
DRUG: golidocitinib

Sponsor

Beijing Tongren Hospital